The BioCT Leadership and Board of Directors brings industry expertise, advice, and support to the Connecticut bioscience community. This team looks forward to serving as mentors and advisors to our members.
Jodie Gillon
President & CEO, BioCT
BioCT
Stanley Choy, M.B.A.
Chair & Treasurer, BioCT
Bioscience Entrepreneur
Paul Hughes, J.D.
Secretary, BioCT
Partner, Wiggin and Dana, LLP
Abhijit (Jit) Banerjee, PhD, MBA
Associate Vice President, Innovation & Entrepreneurship,
University of Connecticut
Robert Bettigole, MPPM
Managing Partner,
Elm Street Ventures
Stanley Choy, M.B.A.
Bioscience Entrepreneur
Josh Geballe, M.B.A.
Senior Associate Provost for Entrepreneurship and Innovation, Yale University;
Managing Director, Yale Ventures
Cynthia D. Green, Ph.D., M.B.A.
Managing Director,
Connecticut Innovations (CI)
Dawn Hocevar
President & CEO,
BioCT
John G. Houston, Ph.D.
President & CEO,
Arvinas
Paul Hughes, J.D.
Partner,
Wiggin and Dana, LLP
Raja Mangipudy, Ph.D.
Senior Vice President, Global Head of Drug Safety Research
and Development, Groton Site Director, Pfizer
David I. Scheer, M.S.
President,
Scheer and Company
Jackie Schumacher
Head of Regulatory and Quality,
Rallybio
Eleanore Seibert, Ph.D.
Vice-President, Drug Metabolism & Pharmacokinetics,
Boehringer Ingelheim Pharmaceuticals, Inc.
Erika Smith, M.B.A.
CEO,
ReNetX Bio, Inc
J. Dormer Stephen, J.D.
Partner,
Shipman & Goodwin, LLP
Kaile Zagger
Healthcare Executive, Director & Co- Founder
Kevin Rakin
Co-Founder,
HighCape Partners
David W. Keiser
Director,
Tetherex Pharmaceuticals
Peter Farina, Ph.D.
Executive in Residence,
Canaan Partners
Frank J. Marco, J.D.
Special Counsel,
Wiggin and Dana, LLP
Harry H. Penner, Jr., LL.M.
Co-Founder &Chairman,
Affinimark
Susan Froshauer, Ph.D.
Past President & CEO,
BioCT